| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Mirati Therapeutics, Inc. | Chief Financial Officer | Common Stock | 102 K | $6.04 M | $59.02 | Aug 9, 2023 | Direct |
| PMV Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 67.5 K | Jun 6, 2024 | Direct | ||
| Mirati Therapeutics, Inc. | Chief Financial Officer | Employee Stock Option (Right to Buy) | 45.5 K | Jan 20, 2023 | Direct | ||
| Surface Oncology, Inc. | Director | Stock Option (Right to Buy) | 24 K | Jun 8, 2022 | Direct | ||
| Spyre Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 11.3 K | May 14, 2024 | Direct | ||
| ARENA PHARMACEUTICALS INC | EVP & Chief Financial Officer | Common Stock | 0 | $98.51 | Mar 11, 2022 | Direct | |
| ARENA PHARMACEUTICALS INC | EVP & Chief Financial Officer | Employee Performance Restricted Stock Unit | 0 | Mar 11, 2022 | Direct | ||
| ARENA PHARMACEUTICALS INC | EVP & Chief Financial Officer | Employee Stock Option (right to buy) | 0 | Mar 11, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| SYRE | Spyre Therapeutics, Inc. | May 14, 2024 | 1 | $0 | 4 | May 16, 2024 | Director |
| AGLE | Spyre Therapeutics, Inc. | Nov 22, 2023 | 1 | $0 | 4 | Nov 27, 2023 | Director |
| AGLE | Spyre Therapeutics, Inc. | Nov 22, 2023 | 0 | $0 | 3 | Nov 27, 2023 | Director |
| MRTX | Mirati Therapeutics, Inc. | Aug 9, 2023 | 1 | $825 K | 4 | Aug 10, 2023 | Chief Financial Officer |
| PMVP | PMV Pharmaceuticals, Inc. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| MRTX | Mirati Therapeutics, Inc. | Jun 2, 2023 | 1 | -$172 K | 4 | Jun 2, 2023 | Chief Financial Officer |
| MRTX | Mirati Therapeutics, Inc. | Jan 20, 2023 | 2 | $0 | 4 | Jan 24, 2023 | CFO |
| SURF | Surface Oncology, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| PMVP | PMV Pharmaceuticals, Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
| MRTX | Mirati Therapeutics, Inc. | Jun 1, 2022 | 2 | $0 | 4 | Jun 3, 2022 | CFO |
| MRTX | Mirati Therapeutics, Inc. | May 16, 2022 | 0 | $0 | 3 | May 16, 2022 | CFO |
| ARNA | ARENA PHARMACEUTICALS INC | Mar 11, 2022 | 6 | $0 | 4 | Mar 11, 2022 | EVP & Chief Financial Officer |
| ARNA | ARENA PHARMACEUTICALS INC | Jan 3, 2022 | 1 | $0 | 4 | Jan 5, 2022 | EVP & Chief Financial Officer |
| SURF | Surface Oncology, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| PMVP | PMV Pharmaceuticals, Inc. | Jun 2, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |